CP-001 Impact of pharmacist led education on cancer chemotherapy. (14th February 2016)

• Record Type: Journal Article
• Authors: Xu, F; Wang, Y
• Is Part Of: European journal of hospital pharmacy. Volume 23(2016)Supplement 1
• Page Start: A1
• Page End: A1
• Publication Date: 2016-02-14
• Subjects: Pharmacy -- Periodicals; Hospital pharmacies -- Periodicals; 615.1
• DOI: 10.1136/ejhpharm-2016-000875.1
• Languages: English
• ISSNs: 2047-9956

Abstract

Abstract : Background: Oncology pharmacy is one of the most active areas of pharmacy practice. How to better serve cancer patients is a noteworthy topic for oncology pharmacists. Purpose: To evaluate the impact of pharmacist led education on cancer chemothearpy. Material and methods: A randomised controlled study was conducted at the department of oncology at our hospital. 155 cancer patients were randomly assigned to a control group (n = 76) or an education group (n = 79), based on a random number table. Patients in the education group were given a booklet 'Skills with cancer patients' and a session with a pharmacist, twice a week, for 2 months. Each session lasted approximately 30 min. Patient in the control group only received conventional chemothearpy without any pharmaceutical care/service. Questionnaires on KAP (knowledge, attitude, practice) and QOL (quality of life) were used to assess the impact of pharmacist education at the end of chemotherapy. Data were analysed with SPSS 13.0 software. Results: During the study, two patients dropped out and two withdrew in the control group while two dropped out in the education group. There were no differences with respect to demographic or clinical characteristics between the two groups. Before the education intervention, there were no significant differences in KAP or QOL scores (baseline values) between the two groups. At the end of the study, knowledge, attitude and behaviour scores were notably increased from 9.94 ± 3.84, 15.64 ± 3.93 and 4.82 ± 0.84 to 17.11 ± 2.11, 22.04 ± 12.38 and 5.69 ± 0.47, respectively, in the education group. In the control group, only knowledge score was increased significantly while no notably change for attitude or behaviour scores. However, the final KAP scores in the education group were significantly increased compared with those in the control group. At the end of study, patients' emotional function and overall quality of life were increased while fatigue, nausea and vomiting, pain, insomina, constipation and diarrhoea scores were decreased significantly in the education group. No significant change occurred in the control group. Between the two groups, significant changes occurred for each score. Conclusion: Educational pharmacy intervention led by clinical pharmacists has a positive role in increasing chemotherapy related knowledge, improving patient's negative emotions, coping better with chemotherapy adverse reactions and ameliorating the QOL of cancer patients. References and/or Acknowledgements: China Guangdong Hospital Pharmacy grant (No.2012ZX001) No conflict of interest.